Surprisingly, 15d-PGJ2 maintained its antiproliferative effects on B cells regardless of the presence of DN PPARγ construct, suggesting PPARγ-independent actions of 15d-PGJ2 in lymphoma cells. This evidence concerns the gene PPARG and lymphoma.